You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Norovirus

Showing 1 - 25 of 384
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Norovirus Infections, Norwalk Gastroenteritis Trial (Human Norovirus Bivalent (G?.1/G?.4)Vaccine,Recombinant (Hansenula

Not yet recruiting
  • Norovirus Infections
  • Norwalk Gastroenteritis
  • Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula polymorpha)
  • placebo
  • (no location specified)
Jun 14, 2023

Gastroenteritis Trial (Recombinant Norovirus Hexavalent Vaccine, Matching Placebo)

Not yet recruiting
  • Gastroenteritis
  • Recombinant Norovirus Hexavalent Vaccine
  • Matching Placebo
  • (no location specified)
Mar 27, 2023

Gastroenteritis Norovirus Trial in Cincinnati (Norovirus GII.4 Challenge Pool)

Recruiting
  • Gastroenteritis Norovirus
  • Norovirus GII.4 Challenge Pool
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center - Infectious Disea
Aug 18, 2022

Norovirus Trial in Ghent (Norovirus GI.4 / GII.4 Bivalent VLP Vaccine (100 µg), Norovirus GI.4 / GII.4 Bivalent VLP Vaccine (300

Completed
  • Norovirus
  • Norovirus GI.4 / GII.4 Bivalent VLP Vaccine (100 µg)
  • +2 more
  • Ghent, Belgium
    Center for Vaccinology (CEVAC), Ghent University and University
Aug 18, 2022

Norovirus Infections, Norwalk Gastroenteritis Trial in Hebi (middle-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine, high-dose

Recruiting
  • Norovirus Infections
  • Norwalk Gastroenteritis
  • middle-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine
  • +2 more
  • Hebi, Henan, China
    qixian Center for Disease Control and Prevention
Oct 26, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN, Placebo Tablets, Norovirus GI.1 Norwalk Virus Inoculum)

Recruiting
  • Norovirus Infections
  • VXA-G1.1-NN
  • +2 more
  • Cypress, California
    AltaSciences LA
Apr 27, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    WCCT Global, Inc.
Sep 19, 2022

Norovirus Infections Trial in Cypress, New Orleans, Austin (VXA-GI.1.NN, Placebo Tablet)

Completed
  • Norovirus Infections
  • VXA-GI.1.NN
  • Placebo Tablet
  • Cypress, California
  • +2 more
Sep 19, 2022

Acute Gastroenteritis Trial in Liuzhou (Low-dose vaccine, High-dose vaccine, Placebo (containing aluminum))

Recruiting
  • Acute Gastroenteritis
  • Low-dose vaccine
  • +3 more
  • Liuzhou, Guangxi, China
    Liuzhou Center for Disease Control and Prevention
Sep 2, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    AltaSciences LA
Apr 27, 2022

Healthy Volunteers, Norovirus Trial in Belgium, United States (NoV Vaccine)

Completed
Has Results
  • Healthy Volunteers
  • Norovirus
  • NoV Vaccine
  • Birmingham, Alabama
  • +10 more
Nov 7, 2022

Norovirus Acute Gastroenteritis Trial in United States (mRNA-1403, mRNA-1405, Placebo)

Not yet recruiting
  • Norovirus Acute Gastroenteritis
  • mRNA-1403
  • +2 more
  • Long Beach, California
  • +14 more
Aug 7, 2023

Gastroenteritis Trial in Rolling Hills Estates, Stockbridge (HIL-214)

Recruiting
  • Gastroenteritis
  • HIL-214
  • Rolling Hills Estates, California
  • +1 more
Aug 2, 2023

Gastroenteritis Trial in Japan (Placebo, HIL-214)

Recruiting
  • Gastroenteritis
  • Placebo
  • HIL-214
  • Fukui-Shi, Japan
  • +3 more
Aug 18, 2023

Norwalk Gastroenteritis, Norovirus Infections Trial in Hebi (Norovirus Bivalent (GI.1 / GII.4) Vaccine(low), Norovirus Bivalent

Completed
  • Norwalk Gastroenteritis
  • Norovirus Infections
  • Norovirus Bivalent (GI.1 / GII.4) Vaccine（low）
  • +4 more
  • Hebi, Henan, China
    qixian Center for Disease Control and Prevention
Apr 20, 2021

Gastroenteritis Norovirus Trial in United States (Nitazoxanide, Placebo)

Active, not recruiting
  • Gastroenteritis Norovirus
  • Chicago, Illinois
  • +11 more
Sep 16, 2021

Norovirus Infection Trial in Cleveland (VXA-G1.1-NN, VXA-G2.4-NS, Placebo Tablets)

Completed
  • Norovirus Infection
  • VXA-G1.1-NN
  • +2 more
  • Cleveland, Ohio
    Rapid Medical Research
Apr 23, 2021

Healthy Volunteers Trial in Great Lakes (NoV Placebo-matching Saline, NoV GI.1/GII.4 Bivalent VLP Vaccine)

Completed
Has Results
  • Healthy Volunteers
  • NoV Placebo-matching Saline
  • NoV GI.1/GII.4 Bivalent VLP Vaccine
  • Great Lakes, Illinois
    Great Lakes Naval Station
May 14, 2021

Norovirus Infections Trial in New Zealand, United States (Open label Bivalent GII.4/GI.1 high dose vaccine 2×10 to the power 11

Recruiting
  • Norovirus Infections
  • Open label Bivalent GII.4/GI.1 high dose vaccine 2×10 to the power 11 IU/dose
  • +3 more
  • La Mesa, California
  • +12 more
Jan 12, 2023

Norovirus Infections Trial in Cincinnati (Donor Breastmilk)

Terminated
  • Norovirus Infections
  • Donor Breastmilk
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Aug 18, 2020

Gastroenteritis Trial in Worldwide (HIL-214, Placebo)

Recruiting
  • Gastroenteritis
  • HIL-214
  • Placebo
  • Chamblee, Georgia
  • +20 more
Jan 31, 2023

Norovirus Trial in United States (Norovirus GI.1/GII.4 Bivalent VLP Vaccine, 0.9% sodium chloride (saline))

Completed
Has Results
  • Norovirus
  • Norovirus GI.1/GII.4 Bivalent VLP Vaccine
  • 0.9% sodium chloride (saline)
  • Birmingham, Alabama
  • +9 more
Apr 22, 2020

Norovirus Infection Trial in Costa Mesa (Norwalk GI.1 Virus)

Completed
Has Results
  • Norovirus Infection
  • Norwalk GI.1 Virus
  • Costa Mesa, California
    WCCT Global
Jan 9, 2020

ABO Blood Group Type Association With COVID-19 Severity

Completed
  • COVID-19
  • +4 more
  • No Intervention
  • Colton, California
    Arrowhead Regional Medical Center
May 15, 2023

Gastroenteritis Trial (HIL-214, Placebo)

Not yet recruiting
  • Gastroenteritis
  • HIL-214
  • Placebo
  • (no location specified)
Apr 26, 2023